Nicotine e-cigarettes for smoking cessation following discharge from smokefree inpatient AOD withdrawal services: A pragmatic randomized controlled trial
presented by Professor Billie Bonevski
E-cigarettes containing nicotine (e-cigarettes) have demonstrated effectiveness for smoking cessation among general populations, but limited evidence in people with substance use disorders (SUD).
E-cigarettes containing nicotine (e-cigarettes) have demonstrated effectiveness for smoking cessation among general populations, but limited evidence in people with substance use disorders (SUD).
Details
When
Wednesday 29 October 2025
1:00pm - 2:00pm
Where
This webinar is suitable for workers in the AOD, mental health, allied health and welfare sectors.
Cost
Free
This presentation will focus on the NEAT Trial, a pragmatic, two-arm, open-label parallel-group randomized controlled trial (n=363) examining the effectiveness of e-cigarettes for smoking abstinence in people with SUD following discharge from smokefree inpatient withdrawal services.
Professor Billie Bonevski is Dean (Research), Director of the Flinders Health and Medical Research Institute (FHMRI), and Matthew Flinders Professor of Public Health at the College of Medicine and Public Health, Flinders University. She is a Behavioural Scientist recognised internationally for her research examining ways to assist people in priority population groups to reduce tobacco smoking.
Register your details
Date: Wednesday 29th Oct, 2025
Venue: Online
Time: 13:00pm – 14:00pm AEST
Cost: Free - Talking Point is a free seminar series but registrations are essential
Register: click here to register there is no cost to attend but registrations are essential